VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

SOHO 2022 | The role of selinexor in DLBCL and the challenges of implementing this agent in patients

Tycel Phillips, MD, City of Hope, Duarte, CA, comments on the role of selinexor in diffuse large B-cell lymphoma (DLBCL), highlighting the adverse events (AEs) associated with this agent and the challenges of implementing it in this patient population. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter